Aguilar-Cordova Estuardo
10% owner at CADL
- Sold, on record
- $443k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Oct 15, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CADLCandel Therapeutics, Inc.10% owner
Sales by reason
0
Routine
0
Plan not stated
2
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice CADLNoticeSep 13, 2024 2024
Filed to sell 28,840 shares ($187k)
Aguilar-Cordova Estuardo, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice CADLNoticeSep 23, 2024 +10 days
Filed to sell 28,480 shares ($199k)
Aguilar-Cordova Estuardo, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale CADLNo planOct 3, 2024 +10 days
Sold 28,788 shares at $6.92 ($199k)
Aguilar-Cordova Estuardo, 10% owner
No 10b5-1 planSold 2.9% of holdings ($6.8M position)959,873 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 4 sale CADLNo planOct 15, 2024 +12 days
Sold 40,412 shares at $6.03 ($244k)
Aguilar-Cordova Estuardo, 10% owner
No 10b5-1 planSold 4.2% of holdings ($5.8M position)919,461 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Oct 15, 2024 | CADL | 10% owner | Form 4 sale | 40,412 | $244k | 4.2% | No plan | SEC |
| Oct 3, 2024 | Oct 3, 2024 | CADL | 10% owner | Form 4 sale | 28,788 | $199k | 2.9% | No plan | SEC |
| Sep 23, 2024 | Sep 23, 2024 | CADL | Director | Form 144 notice | 28,480 | $199k | Notice | SEC | |
| Sep 13, 2024 | Sep 13, 2024 | CADL | Director | Form 144 notice | 28,840 | $187k | Notice | SEC |